help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on January 16, 2007
Molecular Endocrinology, doi:10.1210/me.2006-0221
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, J.
Right arrow Articles by Wong, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, J.
Right arrow Articles by Wong, J.

Submitted on May 24, 2006
Accepted on January 8, 2007

Structural and Functional Analysis of Androgen Receptor in Chromatin

Jiwen Li, Dianzheng Zhang, Junjiang Fu, Zhiqing Huang, and Jiemin Wong*

Dept. of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030

* To whom correspondence should be addressed. E-mail: jwong{at}bcm.tmc.

Androgen receptor (AR), a member of the nuclear receptor superfamily, is a modular protein comprised of a N-terminal domain (NTD), a central DNA binding domain (DBD) and a C-terminal ligand-binding domain (LBD). Previous structural and functional studies have shown that deletion of the LBD generates an AR molecule with full transcriptional activity in many transient transfection assays. In this study we show that deletion of either the NTD1-478 (AR{Delta}N) or LBD680-919 (AR{Delta}C) cripples AR transcriptional activity in chromatin. Both AR{Delta}N and AR{Delta}C mutants are impaired in binding to target genes in chromatin. Overexpression of SRC-1 coactivator partially rescued transcriptional and chromatin-binding defects of AR{Delta}N and AR{Delta}C mutants. Expression of SRC-1 also enhances the binding of the wild-type AR to chromatin, thus revealing a role of SRC-1 in promoting binding of AR to chromatin. We also demonstrate that expression of the AR NTD1-501 in trans can substantially rescue the chromatin binding, but not the transcriptional defect of AR{Delta}N, indicating that binding of AR to chromatin is a step separable from AR induced transcriptional activation. Finally we present evidence that, in contrast to transient transfection, AR NTD alone cannot efficiently activate transcription in chromatin.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society